TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

TAURX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

TAURX

ST13

US500000079183545

Classe

5, 10, 35, 42, 44

Pedido

79183545

Registro

5135047

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

40

Atualização mais recente

08/02/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 35, 42, 44

Data de depósito

22/12/2015

Data de registro

07/02/2017

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

08/12/2023

Última transação

08/02/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

SG

Examinador

DINALLO, KEVIN M

Unidade examinadora

L70

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

TauRx Therapeutics Ltd.

Representantes

Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard & Geralds

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 35Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical and medical preparations for use in relation to neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in relation to neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases

Classe 10

Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely, blood, brain, urine, cerebrospinal fluid analysis and testing apparatus; medical testing apparatus for the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid analysis and tests; surgical and medical apparatus and instruments for facilitating the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid analysis and tests

Classe 35

Retail store services and online retail store services in connection with the sale of pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, surgical and medical apparatus and instruments, apparatus for carrying out tests for medical purposes, scientific and medical apparatus for use in tests; consulting services in the field of medical practice management for others in the fields of neurodegenerative and neurological diseases and disorders, malaria and infectious diseases

Classe 42

Medical, biological, biotechnological, genetic, and pharmaceutical research, design and development services and laboratory research services in the fields of drugs, pharmaceuticals and medicines; research, development and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugs, pharmaceuticals and medicines; exploitation of scientific research and technology, namely, providing advice and information relating to scientific and technological research, researching and developing new products in the fields of drugs, pharmaceuticals and medicines, and scientific research and development services in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugs, pharmaceuticals, medicines, genetics, biology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid

Classe 44

Medical clinic services; health resort services in the nature of medical clinics; services for the provision of medical facilities; medical services; medical advisory services; medical diagnostic testing, monitoring and reporting services; providing medical information, consultancy and advisory services; medical screening information services featuring reminder alerts regarding medical examinations that individuals should undergo for preventative care purposes; medical screening services in the fields of neurodegenerative and neurological diseases and disorders, malaria and infectious diseases; medical services featuring health assessment surveys; consultancy and information services relating to all the aforesaid

Publicações

Histórico de despachos e eventos da marca no USPTO.

40 publicações encontradas

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

07/02/2026

RNWL

INTERNATIONAL REGISTRATION RENEWED

22/01/2026

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

08/12/2023

71AG

REGISTERED-SEC.71 ACCEPTED

08/12/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

21/11/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

15/10/2023

ES71

TEAS SECTION 71 RECEIVED

22/03/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/12/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/12/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/12/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/02/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

16/06/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

26/05/2017

FIMP

FINAL DISPOSITION PROCESSED

26/05/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/05/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

07/02/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

22/11/2016

PUBO

PUBLISHED FOR OPPOSITION

22/11/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/11/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/10/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/10/2016

GNRT

NON-FINAL ACTION E-MAILED

05/10/2016

CNRT

NON-FINAL ACTION WRITTEN

05/10/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/09/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/09/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/09/2016

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

08/09/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/09/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/09/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/09/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/09/2016

RFNP

REFUSAL PROCESSED BY IB

14/05/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

19/04/2016

RFRR

REFUSAL PROCESSED BY MPU

19/04/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

16/04/2016

CNRT

NON-FINAL ACTION WRITTEN

15/04/2016

DOCK

ASSIGNED TO EXAMINER

11/04/2016

MAFR

APPLICATION FILING RECEIPT MAILED

04/03/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

29/02/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

25/02/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace TAURX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.